Could epithelial ovarian cancer be associated with chlamydial infection?

Purpose of investigation: Epithelial ovarian cancer (EOC) is the leading cause of death from gynaecological malignancy in the UK. The pathogenesis of this disease is poorly understood. Our hypothesis was that chlamydial infection might play a role in the pathogenesis of EOC.

Methods: 122 serum samples of patients undergoing surgery for benign or malignant gynaecological conditions were analysed. There was a total of 41 patients with EOC (33.6%), 27 with benign cystadenomas (22.1%) and 54 with normal ovaries (44.3%).

Results: There was a higher incidence of IgA seropositivity and lower incidence of IgG seropositivity in the EOC group compared with the other groups; however, this was not statistically significant. There was no statistical difference in the serum IgM antibodies to chlamydia in the three different groups.

Conclusion: Although chronic infection and persistent inflammation may contribute to the pathogenesis of EOC, and chlamydia is a common genital tract pathogen, our study did not find an association between chlamydia and EOC.

Cancer; Chlamydia; Epithelial ovarian cancer; Infection

[1] Dillner J., Lehtinen M., Bjorge T., Luostarinen T., Youngman L., Jellum E. et al.: "Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer". J. Natl. Cancer Inst., 1997, 89, 1293.

[2] Syrjanen K.J.: "Biology of human papillomavirus (HPV) infec­tions and their role in squamous cell carcinogenesis". Med. Biol., 1987, 65, 21.

[3] Yang H.l., Lu S.N., Liaw Y.F., You S.L., Sun C.A., Wang L.Y. et al.: "Hepatitis B e antigen and the risk of hepatocellular carci­noma". N. Engl. J. Med., 2002, 347. 168.

[4] Axon A.: "Gastric cancer and Helicobacter pylori". Aliment Pharmacol. Ther., 2002, 16 (suppl. 4), 83.

[5] Smith J.S., Munoz N., Herrero R., Eluf-Neto J., Ngelangel C., Franceschi S. et al.: "Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines". J. Infect. Dis., 2002, 185, 324.

[6] Hardiman P., Nieto J.J., MacLean A.B.: "Infertility and ovarian cancer". Gynecol. Oneal., 2000, 76, I.

[7] Tabor E., Kobayashi K.: "Hepatitis C virus, a causative infectious agent of non-A, non-B hepatitis: Prevalence and structure -summary of a conference on hepatitis C virus as a cause of hepa­tocellular carcinoma". J. Natl. Cancer Inst., 1992, 84, 86.

[8] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: "Schistosomes, liver flukes and Helicobacter pylori". IARC Monogr. Eva/. Carcinogenic Risks Hum., 1994, 61, I.

[9] Ames B.N., Gold L.S., Willett W.C.: "The causes and prevention of cancer". Proc. Natl. Acad. Sci. USA, 1995, 92, 5258.

[10] Christen S., Hagen T.M., Shigenaga M.K., Ames B.N.: "Microbes and malignancy: Infection as a cause of human cancer". In: Chronic inflammation, mutation, and cancer. Parsonnet J. (ed.), New York, Oxford University Press, 1999, 35.

[11] Koskela P., Anttila T., Bjorge T., Brunsvig A., Dillner J., Hakama M. et al.: "Chlamydia trachomatis infection as a risk factor for invasive cervical cancer". Int. J. Cancer, 2000, 85, 35.

[12] Anttila T., Saikku P., Koskela P., Bloigu A., Dillner J., IkaheimoI I. et al.: "Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma". JAMA, 2001, 285, 47.

[13] Paavonen J., Lehtinen M.: "Chlamydial pelvic inflammatory disease". Hum. Reprod. Update, 1996, 2, 519.

[14] Fathalla M.F.: "Factors in the causation and incidence of ovarian cancer". Obstet. Gynecol. Surv., 1972, 27, 751.

[15] Ness R.B., Cottreau C.: "Possible role of ovarian epithelial inflammation in ovarian cancer". J. Natl. Cancer Inst., 1999, 91, 1459.

[16] Shu X.O., Brinton L.A., Gao Y.T., Yuan J.M.: "Population-based case-control study of ovarian cancer in Shanghai". Cancer Res., 1989, 49, 3670.

[17] Risch H.A., Howe G.R.: "Pelvic inflammatory disease and the risk of epithelial ovarian cancer". Cancer Epidemiol. Biomarkers Prev., 1995, 4, 447.

[18] Ness R.B., Grisso J.A., Cottreau C., Klapper J., Vergona R., Wheeler J.E. et al.: "Factors related to inflammation of the ovarianepithelium and risk of ovarian cancer". Epidemiology, 2000, II, 111.

[19] Parazzini F., La Vecchia C., Negri E., Moroni S., dal Pino D., Fedele L.: "Pelvic inflammatory disease and risk of ovarian cancer". Cancer Epidemiol. Biomarkers Prev., 1996, 5, 667.

[20] Martin D.C., Khare V.K., Miller B.E., Batzer F.R.: "Association of positive Chlamydia trachomatis and Chlamydia pneumoniae immunoglobulin-gamma titers with increasing age". J. Am. Assoc. Gynecol. Laparosc., 1997, 4, 583.

[21] Ness R.B., Goodman M.T., Shen C., Brunham R.C.: "Serological evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer". J. Infect. Dis., 2003, 187, 1147.